<DOC>
	<DOCNO>NCT02059785</DOCNO>
	<brief_summary>This research Randomized , double-blind , placebo-controlled , multicenter clinical study . Chinese subject Ischemic Stroke .</brief_summary>
	<brief_title>Phase ⅡStudy Pinocembrin Injection Treat Ischemic Stroke</brief_title>
	<detailed_description>Subjects randomly enter one two group , period treatment 14 day , follow-up 90th day .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>3575 hospitalized patient Patients acute stroke ≤24h NIHSS score 620 time enrollment , score ≥2 item 5 and/or 6 For first time always without obvious sequela stroke disease ( mRS≤1） Informed consent The disease Acute intracerebral hemorrhage , tumor encephalitis cause similar symptom Patient NIHSS level consciousness score≥2 dementia , patient investigator think n't fit study TIA Symptoms disease rapidly improve randomize Severe hypertension ( SBP &gt; 200 mmHg DBP &gt; 110 mmHg ) Inadequate liver function ( AST ALT great 2 time upper limit normal value ) ; Renal impairment ( Creatinine clearance ＜60ml/min） Severe system viscera organic disease Have use neuroprotectant experimental drug Patient unlikely complete study due severe clinical condition Pregnant breastfeed Participation previous clinical study within 30 day Meets exclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Pinocembrin Injection</keyword>
	<keyword>Placebo</keyword>
	<keyword>mRS</keyword>
</DOC>